Pharmaceutical products
Originaltitel der Bekanntmachung
Bulgaria-Sofia: Pharmaceutical products
Opportunity Score
Warum diese Bewertung?
Chance
60 / 100
Komplexität
40 / 100
Risikofaktoren
Procurement documents were not analyzed. Critical details (e.g., full product list, contract terms, technical specifica...
DPS may attract many bidders due to low barriers; price-only award increases competition.
Restricted procedure — pre-qualification required
Tiefe Portfolioanalyse
Verwendet:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications
Überblick
Strong opportunityWichtige Fakten
- BGN 8.7M estimated value
- Supplies contract
- Supply of various pharmaceutical products to Pirogov Hospital, Sofia.
- Products are grouped into nomenclature units (sub-lots), but no detailed list provided in the notice.
Vollständige Zusammenfassung anzeigen
Establishment of a Dynamic Purchasing System (DPS) for the supply of pharmaceutical products to Pirogov Hospital in Sofia, Bulgaria. The DPS has an estimated total value of 8,695,574 BGN and a duration of 36 months (until 29 December 2026). This is a restricted procedure, with award based on lowest price. Eligibility includes a minimum turnover of 100,000 BGN over the last three years and possession of a wholesale distribution license. The notice is a DPS creation, and no specific lot breakdown is provided; the system covers multiple nomenclature units. Procurement documents were not analyzed.
Risiken
Procurement documents were not analyzed. Critical details (e.g., full product list, contract terms, technical specifica...
DPS may attract many bidders due to low barriers; price-only award increases competition.
Restricted procedure — pre-qualification required
No procurement documents available
Analyse kann unvollständig sein
Nur ein Teil der Vergabeunterlagen wurde analysiert. Weitere Anforderungen, Zertifikate oder Einreichungsdokumente können in den übrigen Unterlagen enthalten sein.
Wichtige Anforderungen
Technical
- No technical or professional capacity requirement is imposed.
Eligibility
- Minimum total turnover of 100,000 BGN over the last three financial years.
Certifications
- Tenderers must hold a wholesale distribution license for pharmaceuticals or equivalent, as per Bulgarian law.
Anforderungen können unvollständig sein.
Auftraggeber
Ort
гр. София, BGR
Website
Auftraggeberprofil
Kennung
130345786
Tätigkeit
Health
Vergabedetails
- Veröffentlichungsdatum
- 02 Jan 2024
- Sprachen
- Bulgarian
Referenzmetadaten
- Rechtsgrundlage
- 32014L0024
Referenz-IDs
- Ausschreibungs-ID
- 3311-2024
Ähnliche Ausschreibungen
Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Orylmyte(R) (ATC-Code nach WHO: V01AA03)
Bulgaria – Pharmaceutical products – Динамична система за покупки за доставка на лекарствени продукти за Медицински институт на МВР
Belgium – Pharmaceutical products – Antimycotica
Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Oralair(R) (ATC-Code nach WHO: V01AA02)
Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Ipratropiumbromid (ATC-Code nach WHO: R03BB01)
Denmark – Pharmaceutical products – Amgros 2027 1.1170.a
Opportunity Score
Warum diese Bewertung?
Chance
60 / 100
Komplexität
40 / 100
Risikofaktoren
Procurement documents were not analyzed. Critical details (e.g., full product list, contract terms, technical specifica...
DPS may attract many bidders due to low barriers; price-only award increases competition.
Restricted procedure — pre-qualification required
Tiefe Portfolioanalyse
Verwendet:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications